Michael F. Demane - Apr 12, 2023 Form 4 Insider Report for NEVRO CORP (NVRO)

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Stock symbol
NVRO
Transactions as of
Apr 12, 2023
Transactions value $
$1,445,238
Form type
4
Date filed
4/14/2023, 04:22 PM
Previous filing
Apr 4, 2023
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Options Exercise $1.45M +80.3K +387.37% $18.00 101K Apr 12, 2023 Direct F1
holding NVRO Common Stock 164K Apr 12, 2023 See footnote F2
holding NVRO Common Stock 82.5K Apr 12, 2023 See footnote F3
holding NVRO Common Stock 91.2K Apr 12, 2023 See footnote F4
holding NVRO Common Stock 18.3K Apr 12, 2023 See footnote F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVRO Stock Option (Right to Buy) Options Exercise $0 -80.3K -100% $0.00* 0 Apr 12, 2023 Common Stock 80.3K $18.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,155 restricted stock units.
F2 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F4 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F5 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.
F6 The shares subject to the option are fully vested and exercisable.